Sasa Veitchii Extracts Suppress Acetaminophen-induced Hepatotoxicity in Mice
Overview
Public Health
Affiliations
Background: The aim of this study was to investigate the therapeutic effects of a Sasa veitchii leaf extract (SE) on acetaminophen (APAP)-induced hepatotoxicity.
Methods: Seven-week-old male ddY mice were orally administered SE or saline (0.2 mL) once a day for a week. Twenty-four hours after the last pretreatment, the mice were intraperitoneally injected with 550 mg/kg APAP or saline under fasting conditions. The mice from each group were euthanized and bled for plasma analysis 2, 6, 24, and 72 h after the injection.
Results: We found that pretreatment with SE significantly decreased hepatic injury markers (i.e., alanine aminotransferase and aspartate aminotransferase), oxidative stress (malondialdehyde and glutathione level), inflammatory cytokines, histological damage, c-jun N-terminal kinase activation, and receptor-interacting protein-1 activation. Further, SE pretreatment decreased Cyp2e1 expression and increased total antioxidant capacity in the liver.
Conclusion: Our findings demonstrate that prophylactic SE treatment protects mice from APAP-induced hepatotoxicity through modulation of Cyp2e1 expression and antioxidant capacity.
Pandey B, Thapa S, Kaundinnyayana A, Panta S Food Sci Nutr. 2024; 12(9):6482-6497.
PMID: 39554326 PMC: 11561823. DOI: 10.1002/fsn3.4288.
Tsukiboshi Y, Mikami Y, Horita H, Ogata A, Noguchi A, Yokota S Nagoya J Med Sci. 2024; 86(2):223-236.
PMID: 38962411 PMC: 11219230. DOI: 10.18999/nagjms.86.2.223.
Copper-induced diurnal hepatic toxicity is associated with Cry2 and Per1 in mice.
Tominaga S, Yoshioka H, Yokota S, Tsukiboshi Y, Suzui M, Nagai M Environ Health Prev Med. 2023; 28:78.
PMID: 38092388 PMC: 10739358. DOI: 10.1265/ehpm.23-00205.
extract induces anticancer effects via inhibition of cyclin D1 expression in MCF-7 cells.
Ichimaru Y, Kanaeda N, Tominaga S, Suzui M, Maeda T, Fujii H Nagoya J Med Sci. 2020; 82(3):509-518.
PMID: 33132435 PMC: 7548257. DOI: 10.18999/nagjms.82.3.509.
Tafere G, Tuem K, Gebre A, Balasubramaniam R J Exp Pharmacol. 2020; 12:301-311.
PMID: 32982486 PMC: 7493212. DOI: 10.2147/JEP.S259081.